Details for New Drug Application (NDA): 206276
✉ Email this page to a colleague
The generic ingredient in PATADAY ONCE DAILY RELIEF is olopatadine hydrochloride. There are seventeen drug master file entries for this compound. Forty-three suppliers are listed for this compound. Additional details are available on the olopatadine hydrochloride profile page.
Summary for 206276
Tradename: | PATADAY ONCE DAILY RELIEF |
Applicant: | Alcon Labs Inc |
Ingredient: | olopatadine hydrochloride |
Patents: | 2 |
Pharmacology for NDA: 206276
Mechanism of Action | Histamine H1 Receptor Antagonists |
Physiological Effect | Decreased Histamine Release |
Medical Subject Heading (MeSH) Categories for 206276
Suppliers and Packaging for NDA: 206276
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
PATADAY ONCE DAILY RELIEF | olopatadine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 206276 | NDA | Alcon Laboratories, Inc. | 0065-0816 | 0065-0816-01 | 2 BOTTLE, PLASTIC in 1 CARTON (0065-0816-01) / 2.5 mL in 1 BOTTLE, PLASTIC |
PATADAY ONCE DAILY RELIEF | olopatadine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 206276 | NDA | Alcon Laboratories, Inc. | 0065-0816 | 0065-0816-02 | 1 BOTTLE, PLASTIC in 1 CARTON (0065-0816-02) / .5 mL in 1 BOTTLE, PLASTIC |
Profile for product number 001
Active Rx/OTC/Discontinued: | OTC | Dosage: | SOLUTION/DROPS;OPHTHALMIC | Strength | EQ 0.7% BASE | ||||
Approval Date: | Jan 30, 2015 | TE: | RLD: | Yes | |||||
Patent: | ⤷ Sign Up | Patent Expiration: | May 19, 2032 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
Patented Use: | TREATMENT OF OCULAR ITCHING ASSOCIATED WITH ALLERGIC CONJUNCTIVITIS | ||||||||
Patent: | ⤷ Sign Up | Patent Expiration: | May 19, 2032 | Product Flag? | Y | Substance Flag? | Delist Request? |
Complete Access Available with Subscription